Kan. Admin. Regs. § 68-21-7 - Drugs of concern

(a) Each of the following shall be classified as a drug of concern:
(1) Any product containing all three of these drugs: butalbital, acetaminophen, and caffeine;
(2) any compound, mixture, or preparation that contains any detectable quantity of ephedrine, its salts or optical isomers, or salts of optical isomers and is exempt from being reported to the statewide electronic logging system for the sale of methamphetamine precursors;
(3) any compound, mixture, or preparation that contains any detectable quantity of pseudoephedrine, its salts or optical isomers, or salts of optical isomers and is exempt from being reported to the statewide electronic logging system for the sale of methamphetamine precursors;
(4) promethazine with codeine; and
(5) any product, compound, mixture, or preparation that contains gabapentin.
(b) Each request to have a drug added to the program for monitoring shall be submitted in writing to the board.

This regulation shall take effect 90 days after publication in the Kansas register.

Notes

Kan. Admin. Regs. § 68-21-7
Authorized by K.S.A. 2016 Supp. 65-1692; implementing K.S.A. 2016 Supp. 65-1682; effective Oct. 15, 2010; amended Feb. 4, 2015; amended by Kansas Register Volume 37, No. 17; effective 5/11/2018.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.